Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease
Marcus E. Risner(Research Triangle Park Foundation), Ann M. Saunders(GlaxoSmithKline (United States)), Jill F.B. Altman(GlaxoSmithKline (United Kingdom)), George C. Ormandy(GlaxoSmithKline (United Kingdom)), Suzanne Craft(University of Washington), I. Foley(GlaxoSmithKline (United Kingdom)), Marina Zvartau‐Hind(GlaxoSmithKline (United Kingdom)), David A. Hosford(GlaxoSmithKline (United States)), A D Roses(GlaxoSmithKline (United Kingdom)), for the Rosiglitazone in Alzheimer's Disease Study Group
Cited by 681
Abstract
Related Papers
No related papers found
Powered by citation graph analysis